Hanmi wins Korean patent for egg-derived protein drug

Published: 2003-04-22 06:56:00

Updated: 2003-04-22 06:56:00

Hanmi Pharm said on April 17 that it acquired a patent related to a core technology of producing a variety of high-price protein drugs from a transgenic hen (title: Multinfunctional embryonic reproduction cell line of birds and its manufacturing method).

An official of Hanmi said, "This paten...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK